by Michael Benatar | Dec 11, 2020 | Events, Press Releases, Research Highlights
For more than a decade, investigators at the University of Miami Miller School of Medicine have been studying the earliest signs of amyotrophic lateral sclerosis (ALS). Now, armed with biomarkers and findings from their Pre-Symptomatic Familial ALS (Pre-fALS) study,...
by Michael Benatar | Oct 18, 2020 | Events, Press Releases, Research Highlights
The first Pre-Symptomatic ALS Workshop, organized and hosted by Dr. Michael Benatar (University of Miami), took place in Miami on January 27th, 2020. This Workshop brought together ~40 specialists in the fields of ALS, frontotemporal dementia (FTD), other...
by Michael Benatar | Sep 10, 2020 | Events, Research Highlights
To help raise awareness about rare diseases, the National Center for Advancing Translation Science (NCATS) hosts an annual ‘Rare Diseases are Not Rare’ challenge. Members of the ALS Center research team participated in this challenge. Please see below to view our...
by Michael Benatar | Jul 23, 2020 | Press Releases, Research Highlights
On June 29, 2020, Governor Ron DeSantis approved $800,000 in funding for the Bitner Plante ALS Initiative of Florida in the 2020-2021 budget. This Initiative provides support for ALS patients receiving treatment at 4 different multidisciplinary clinics within the...
by admin | Aug 28, 2018 | Research Highlights
Data presented at international symposium demonstrate safety and preliminary evidence of efficacy Arimoclomol, a heat shock protein-based therapy, shows promise for the treatment of amyotrophic lateral sclerosis, or ALS, based on the results of a phase II trial...
by admin | Aug 28, 2018 | Research Highlights
The absence of suitable biomarkers for amyotrophic lateral sclerosis (ALS) poses a major obstacle to therapy development. For this reason, the discovery and validation of potential disease progression and pharmacodynamic biomarkers has been one of the top priorities...
